Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Journal of Immunology Research|December 2, 2014
A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsEleni-Kyriaki Vetsika, Filippos Koinis, Marianthi Gioulbasani, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 26, 2019
Nuclear localization of PD-L1: artifact or reality?Hara Polioudaki, Amanda Chantziou, Konstantina Kalyvianaki, et al.
Clinical Biochemistry|August 19, 2006
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridizationMaria Ntoulia, Loukas Kaklamanis, Christos Valavanis, et al.
International Journal of Cancer|December 30, 2003
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapseAlexandra Giatromanolaki, Michael I Koukourakis, Stelios Kakolyris, et al.
Molecular Oncology|August 3, 2017
Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomesMaria Spiliotaki, Dimitris Mavroudis, Maria Kokotsaki, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2004
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding studyCharalambos Kouroussis, Dimitris Mavroudis, Stylianos Kakolyris, et al.
Plos One|August 20, 2014
KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancerAristea Kalikaki, Helen Politaki, John Souglakos, et al.
Cancer Chemotherapy and Pharmacology|April 30, 2010
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trialOurania Katopodis, Aris Polyzos, Nikolaos Kentepozidis, et al.
Anticancer Research|November 27, 2008
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trialIoannis Gioulbasanis, Zacharenia Saridaki, Antonia Kalykaki, et al.
Breast Cancer Research : BCR|November 19, 2009
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patientsGalatea Kallergi, Harris Markomanolaki, Vicky Giannoukaraki, et al.
Pageof 12